Skip to content

Effect of double pass PDL in treatment of PWS

To investigate the efficacy and safety of single pass Pulsed Dye Laser (PDL) with double pass Pulsed Dye Laser(PDL) ,within 20 minutes interval, for treatment of port wine stain(PWS)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180815040808N1
Enrollment
23
Registered
2019-02-02
Start date
2019-01-30
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Port wine stain. Congenital non-neoplastic naevus

Interventions

Intervention 1: Intervention group 1 :Twenty three patients who have port wine stain included in the study.One part of the lesion which has been choosed randomly will recieve long pulse PDL laser wit

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have congenital port wine stain are included in the study Patients are at least 10 years old Patients should fill the informed concent before inclusion in the study

Exclusion criteria

Exclusion criteria: Patients who have treated the port wine stain previously Children who can not tolerate laser without general anesthesia

Design outcomes

Primary

MeasureTime frame
Evaluation the degree of erythema of the lesion. Timepoint: Before starting the treatment and one month after the last (third) session of the laser. Method of measurement: photographs taken on months 0 and 1 month after last treatment and analyze with visioface device( to determine of reducing erythma in quantity) and photofinder (to evaluate the microscopic features of the vessels before treatment and evaluate the exact reduction in erythema quantity).

Secondary

MeasureTime frame
Laser side effects. Timepoint: Monthly. Method of measurement: According to physical exam and pictures.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Razavi

Tehran University of Medical Sciences

Razavi_z@razi.tums.ac.ir+98 21 5561 8989

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026